Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Changes To “Old” Dietary Ingredients Do Not Make Them “New” – CRN, NNFA

This article was originally published in The Tan Sheet

Executive Summary

Manufacturers who modify a recommended dose or processing method for an "old" ingredient should not submit a New Dietary Ingredient notification to FDA, according to Feb. 1 comments from the Council for Responsible Nutrition

You may also be interested in...



Dietary Supplement Reps Ask FDA For Clarity Across The Board On NDIs

FDA should focus the 75-day premarket notification process specifically on ingredients, not finished products, industry stakeholders asserted at the agency's public meeting on new dietary ingredient (NDI) submissions Nov. 15

DSHEA Strategy: “Signal Detection” Is First Defense To Detect Adverse Events

FDA will employ a "signal detection" process for evaluating and monitoring safety issues related to supplements on the market

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS097811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel